Last reviewed · How we verify
NCT04768725
Combined Physical-cognitive Exercise and Dietary Intervention for Postmenopausal Obese Women
NA trial testing Dietary intervention combined with physical-cognitive exergaming in Obesity in 92 participants. Completed in 5 December 2022.
3 December 2022
Quick facts
| Lead sponsor | Chiang Mai University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 92 |
| Start date | 26 September 2021 |
| Primary completion | 3 December 2022 |
| Estimated completion | 5 December 2022 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Dietary intervention combined with physical-cognitive exergaming
- Dietary intervention
- Physical-cognitive intervention
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Chiang Mai University
Who can join
Adults 45 to 59, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effects of dietary intervention combined with physical-cognitive exergaming on cognitive performance and circulating biomarkers of obese postmenopausal women. It is hypothesized that participants will demonstrate significant improvement in cognitive performance and circulating biomarkers after participating in this combined program compared to baseline and the dietary and control groups.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: a randomized controlled trial.
Keawtep P, Sungkarat S, Boripuntakul S, Sa-Nguanmoo P, et al · · 2024 · cited 31× · PMID 38443944 · DOI 10.1186/s12966-024-01580-z -
Fasting and Exercise in Oncology: Potential Synergism of Combined Interventions.
Wilson RL, Kang DW, Christopher CN, Crane TE, et al · · 2021 · cited 5× · PMID 34684421 · DOI 10.3390/nu13103421
Verify or expand the search:
- PubMed search for NCT04768725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Chiang Mai University trials
Trials by the same sponsor.
- NCT07366775 — A Telenursing Program to Support Diabetes Self-Management · NA · active not recruiting
- NCT07032610 — Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents · not yet recruiting
- NCT06978621 — Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV · Phase 3 · recruiting
- NCT06905041 — Preoperative Anemia Affected to Postoperative Outcomes in Liver Resection · not yet recruiting
- NCT07476404 — Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04768725 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chiang Mai University
- Last refreshed: 14 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04768725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing